Food Drug Administration ALS Treatment – CWEB.com
Hope for ALS Treatment. The FDA approved a new drug to treat ALS today!!! Pressure from the patient community is having a positive effect. Great news for ALS patients, especially those in the early stages. Lets hope this opens the flood gates for several more treatments this year and next year!
The Food and Drug Administration announced today it has granted approval to MT Pharma America to begin marketing edaravone as a treatment for amyotrophic lateral sclerosis (ALS). The approval of edaravone marks the first new treatment to be approved for ALS in the United States since Rilutek® (Riluzole) was approved in 1995.
“This announcement is an important one. The approval gives people with ALS and their doctors a new treatment option to explore together. ALS is a complex disorder and it will require multiple different approaches to bring relief to all those diagnosed with ALS. With several additional potential treatments in clinical trials today, this is a uniquely hopeful time for the ALS community,” said Steve Perrin, Ph.D., CEO & CSO of the ALS Therapy Development Institute (ALS TDI).
The ALS Therapy Development Institute will hold a public webinar in the coming days to discuss edaravone with the ALS community. Advance registration required at https://www.als.net/als-webinars/.